Investigating the Role of GDE2 in Neuronal Mitotic Inhibition and Nuclear Pore Complex Defects
研究 GDE2 在神经元有丝分裂抑制和核孔复合体缺陷中的作用
基本信息
- 批准号:10591488
- 负责人:
- 金额:$ 4.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-13 至 2024-04-12
- 项目状态:已结题
- 来源:
- 关键词:ALS patientsAddressAdultAffectAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease brainAlzheimer&aposs disease patientAmyotrophic Lateral SclerosisAutopsyBrainCell CycleCell Cycle InhibitionCell Cycle ProgressionCell Cycle RegulationCell surfaceCellular biologyChronologyDataDefectDementiaDevelopmentDiseaseDissectionEmbryonic DevelopmentEnzymesEtiologyExhibitsFunctional disorderGPI Membrane AnchorsGenetic EpistasisGrantHumanImmunohistochemistryImpairmentIn VitroInhibition of Cell ProliferationKnock-outKnockout MiceKnowledgeLifeMaintenanceMediatingMembraneMentorsMentorshipMitosisMitoticMitotic Cell CycleMolecularMotor CortexMusNational Research Service AwardsNerve DegenerationNeurodegenerative DisordersNeuronal DifferentiationNeuronsNeurosciencesNuclear EnvelopeNuclear Pore ComplexOutcomePathogenesisPathologicPathologyPathway interactionsPersonsPhenotypePhysiologicalPrimary Cell CulturesProcessProteinsPublic HealthRNA analysisResearchRoleSamplingScientistSeveritiesSignal TransductionStructureTechnical ExpertiseTestingTherapeutic InterventionTimeTrainingTransmission Electron MicroscopyUbiquitinationViralVirusWNT Signaling PathwayWorkWritingbrain tissuecollaborative environmentdesign and constructioneffective therapyexperimental studyglycerophosphodiester phosphodiesterasehuman diseasehuman tissueimprovedin vivoinsightknockout animalmouse geneticsneuronal survivalnew therapeutic targetnovelnucleocytoplasmic transportpostmitoticpreventskillsstem cell proliferationteachertherapeutic candidatetissue preparationtranscriptome sequencing
项目摘要
Project Summary / Abstract
Alzheimer's disease (AD) and related diseases (ADRDs) are the leading cause of dementia, affecting millions of
people each year. Despite being such a prevalent public health concern, knowledge of the etiology of
neurodegeneration in these diseases is limited and has stymied the development of effective treatments.
Aberrant neuronal cell-cycle reentry (CCR) and nuclear pore complex (NPC)/nucleocytoplasmic transport
defects have been separately identified as causal phenomena for neurodegeneration in AD and ADRDs.
However, the mechanisms leading to these phenomena and the relationship between them remains unknown.
We have identified a pathway involving Glycerophosphodiester phosphodiesterase 2 (GDE2 or GDPD5) that
prevents CCR and NPC/nucleocytoplasmic transport defects in the adult mammalian brain and is disrupted in
human postmortem AD and ALS brain tissue. GDE2 is one of three six-transmembrane enzymes that act at the
cell surface to cleave the GPI-anchor that tethers some proteins to the membrane. During embryogenesis, GDE2
inhibits progenitor cell proliferation to promote neuronal differentiation. Preliminary studies show that loss of
GDE2 in the adult brain leads to CCR and NPC abnormalities that precede overt neurodegeneration. Because
NPC defects are coincident with CCR in neurons lacking GDE2, and the NPC normally breaks down during
mitosis, we hypothesize that GDE2 is important for maintaining neurons in a postmitotic state throughout life and
that aberrant CCR elicited by GDE2 loss leads to NPC breakdown and neurodegeneration. Importantly, GDE2
localization and function is disrupted in AD and ADRDs, raising the possibility that dysfunction of the GDE2
pathway could contribute to the pathogenesis of these diseases. This proposal will test our central hypothesis in
three aims. Aim 1 will define the physiological requirement for GDE2 in maintaining neuronal quiescence and
NPC integrity in aging mice while Aim 2 will define the relationship between CCR and NPC breakdown and
identify the mechanisms leading to CCR and NPC defects. Later experiments will determine relevance of this
pathway to CCR and NPC disruption in human AD and ADRDs (Aim 3). The proposed research is expected to
identify a novel physiological pathway that is essential for neuronal survival and will provide new insight into
causal mechanisms of neurodegeneration that are relevant to human disease. In addition, this project has
immense training potential. I will have the opportunity to improve my knowledge in neuroscience and cell biology,
and to acquire technical expertise in primary cell culture, viral construct design and transduction, mouse genetics,
brain dissections and tissue preparation, and immunohistochemical analysis of human tissues. This research
will be performed in a highly collaborative environment, where I will have numerous opportunities to receive
quality mentorship and training, to develop my written and presentation skills, and to grow as a mentor and
teacher to more junior scientists. Overall, the Kirschstein-NRSA grant will support both my research aimed at
discovering the molecular basis of neurodegeneration and my development as an independent scientist.
项目摘要/摘要
阿尔茨海默病(AD)和相关疾病(ADRD)是导致痴呆症的主要原因,影响着数百万人
每年都有人。尽管这是一个如此普遍的公共卫生问题,但对该病病因的了解
这些疾病中的神经变性是有限的,并阻碍了有效治疗方法的发展。
异常神经细胞周期折返与核孔复合体/核质转运
缺陷分别被认为是AD和ADRDS中神经退行性变的原因现象。
然而,导致这些现象的机制以及它们之间的关系尚不清楚。
我们已经确定了一条涉及甘油磷酸二酯磷酸二酯酶2(GDE2或GDPD5)的途径,该途径
在成年哺乳动物脑中防止CCR和NPC/核质运输缺陷,并在
人死后AD和ALS脑组织。GDE2是三种作用于细胞外基质的六种跨膜酶之一
细胞表面切割将一些蛋白质系在膜上的GPI锚。在胚胎发育过程中,GDE2
抑制祖细胞增殖,促进神经元分化。初步研究表明,
成人大脑中的GDE2会导致CCR和NPC的异常,这些异常发生在明显的神经变性之前。因为
在缺乏GDE2的神经元中,NPC缺陷与CCR一致,并且NPC通常在
有丝分裂,我们假设GDE2对维持神经元在一生中处于有丝分裂后状态和
GDE2缺失引起的Ccr异常导致鼻咽癌的崩溃和神经退行性变。重要的是,GDE2
AD和ADRDS的定位和功能被破坏,增加了GDE2功能障碍的可能性
途径可能参与了这些疾病的发病机制。这项提议将检验我们的中心假设
三个目标。目标1将定义GDE2在维持神经元静止和
衰老小鼠鼻咽癌的完整性,而目标2将定义CCR和鼻咽癌破裂的关系和
找出导致CCR和NPC缺陷的机制。稍后的实验将确定这一点的相关性
人类AD和ADRDS中CCR和NPC破坏的途径(目标3)。这项拟议的研究预计将
确定对神经元生存至关重要的新的生理途径,并将提供新的见解
与人类疾病相关的神经退行性变的原因机制。此外,这个项目还有
巨大的训练潜力。我将有机会提高我在神经科学和细胞生物学方面的知识,
并获得原代细胞培养、病毒结构设计和转导、小鼠遗传学、
脑部解剖和组织准备,以及人体组织的免疫组织化学分析。这项研究
将在高度协作的环境中表演,在那里我将有很多机会获得
高质量的指导和培训,发展我的写作和演讲技能,并成长为一名导师和
更多初级科学家的老师。总体而言,Kirschstein-NRSA拨款将支持我的两项研究,旨在
发现神经退行性变的分子基础和我作为一名独立科学家的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anna Nicole Westerhaus其他文献
Anna Nicole Westerhaus的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anna Nicole Westerhaus', 18)}}的其他基金
Investigating the Role of GDE2 in Neuronal Mitotic Inhibition and Nuclear Pore Complex Defects
研究 GDE2 在神经元有丝分裂抑制和核孔复合体缺陷中的作用
- 批准号:
10231661 - 财政年份:2021
- 资助金额:
$ 4.77万 - 项目类别:
Investigating the Role of GDE2 in Neuronal Mitotic Inhibition and Nuclear Pore Complex Defects
研究 GDE2 在神经元有丝分裂抑制和核孔复合体缺陷中的作用
- 批准号:
10392339 - 财政年份:2021
- 资助金额:
$ 4.77万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 4.77万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 4.77万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 4.77万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 4.77万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 4.77万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 4.77万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 4.77万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 4.77万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 4.77万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 4.77万 - 项目类别:
Research Grant














{{item.name}}会员




